Megan Smeykal - 21 Feb 2023 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Chief Accounting Officer, Controller
Signature
/s/ Megan Smeykal
Issuer symbol
TELA
Transactions as of
21 Feb 2023
Net transactions value
$0
Form type
4
Filing time
23 Feb 2023, 15:10:49 UTC
Previous filing
01 Apr 2022
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +9,400 +78% $0.000000 21,489 21 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units will vest in four equal annual installments beginning on February 21, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates.